Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity

v3.25.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Class A and Class B Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2024   273,265,000        
Beginning balance (in shares) at Jan. 31, 2024       14,131,000    
Beginning balance at Jan. 31, 2024 $ 679,704 $ 8 $ 1,182,150 $ (23,831) $ (3,836) $ (474,787)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation - equity classified awards 29,629   29,629      
Exercise of stock options and vesting of restricted stock units (in shares)   5,106,000        
Exercise of stock options and vesting of restricted stock units 17,235   17,235      
Issuance of common shares upon ESPP purchases (in shares)   455,000        
Issuance of common shares upon ESPP purchases 3,403   3,403      
Common stock repurchased, including accrued excise tax (in shares)   (25,460,000)        
Common stock repurchased, including accrued excise tax (273,064)         (273,064)
Other comprehensive income (loss) (415)       (415)  
Net income 12,475         12,475
Ending balance (in shares) at Jul. 31, 2024   253,366,000        
Ending balance (in shares) at Jul. 31, 2024       14,131,000    
Ending balance at Jul. 31, 2024 468,967 $ 8 1,232,417 $ (23,831) (4,251) (735,376)
Beginning balance (in shares) at Apr. 30, 2024   268,114,000        
Beginning balance (in shares) at Apr. 30, 2024       14,131,000    
Beginning balance at Apr. 30, 2024 610,931 $ 8 1,205,948 $ (23,831) (5,224) (565,970)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation - equity classified awards 15,473   15,473      
Exercise of stock options and vesting of restricted stock units (in shares)   1,917,000        
Exercise of stock options and vesting of restricted stock units 7,593   7,593      
Issuance of common shares upon ESPP purchases (in shares)   454,000        
Issuance of common shares upon ESPP purchases 3,403   3,403      
Common stock repurchased, including accrued excise tax (in shares)   (17,119,000)        
Common stock repurchased, including accrued excise tax (171,247)         (171,247)
Other comprehensive income (loss) 973       973  
Net income 1,841         1,841
Ending balance (in shares) at Jul. 31, 2024   253,366,000        
Ending balance (in shares) at Jul. 31, 2024       14,131,000    
Ending balance at Jul. 31, 2024 $ 468,967 $ 8 1,232,417 $ (23,831) (4,251) (735,376)
Beginning balance (in shares) at Jan. 31, 2025   255,443,000        
Beginning balance (in shares) at Jan. 31, 2025 14,130,784     14,131,000    
Beginning balance at Jan. 31, 2025 $ 612,063 $ 8 1,268,920 $ (23,831) (6,969) (626,065)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation - equity classified awards 43,805   43,805      
Exercise of stock options and vesting of restricted stock units (in shares)   5,742,000        
Exercise of stock options and vesting of restricted stock units 12,939   12,939      
Issuance of common shares upon ESPP purchases (in shares)   412,000        
Issuance of common shares upon ESPP purchases 2,785   2,785      
Common stock repurchased, including accrued excise tax (in shares)   (16,495,000)        
Common stock repurchased, including accrued excise tax (141,429) $ (1)       (141,428)
Other comprehensive income (loss) 2,227       2,227  
Net income $ 11,047         11,047
Ending balance (in shares) at Jul. 31, 2025   245,102,000        
Ending balance (in shares) at Jul. 31, 2025 14,130,784     14,131,000    
Ending balance at Jul. 31, 2025 $ 543,437 $ 7 1,328,449 $ (23,831) (4,742) (756,446)
Beginning balance (in shares) at Apr. 30, 2025   257,899,000        
Beginning balance (in shares) at Apr. 30, 2025       14,131,000    
Beginning balance at Apr. 30, 2025 639,772 $ 8 1,293,880 $ (23,831) (2,652) (627,633)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation - equity classified awards 21,692   21,692      
Exercise of stock options and vesting of restricted stock units (in shares)   3,286,000        
Exercise of stock options and vesting of restricted stock units 10,092   10,092      
Issuance of common shares upon ESPP purchases (in shares)   412,000        
Issuance of common shares upon ESPP purchases 2,785   2,785      
Common stock repurchased, including accrued excise tax (in shares)   (16,495,000)        
Common stock repurchased, including accrued excise tax (141,429) $ (1)       (141,428)
Other comprehensive income (loss) (2,090)       (2,090)  
Net income $ 12,615         12,615
Ending balance (in shares) at Jul. 31, 2025   245,102,000        
Ending balance (in shares) at Jul. 31, 2025 14,130,784     14,131,000    
Ending balance at Jul. 31, 2025 $ 543,437 $ 7 $ 1,328,449 $ (23,831) $ (4,742) $ (756,446)